Interstitial Fibrosis and Arrhythmic Mitral Valve Prolapse: Unraveling Sex-Based Differences
Author Information
Author(s): Tastet Lionel, Dixit Shalini, Jhawar Rohit, Nguyen Thuy, Al-Akchar Mohammad, Bibby Dwight, Arya Farzin, Cristin Luca, Anwar Shafkat, Higuchi Satoshi, Hsia Henry, Lee Yoo Jin, Delling Francesca
Primary Institution: University of California, San Francisco
Hypothesis
Among individuals with arrhythmic mitral valve prolapse (AMVP) and without significant mitral regurgitation, interstitial fibrosis as quantified by global ECV% on CMR is increased, suggesting a primary myopathy, and the relationship between interstitial fibrosis and ventricular arrhythmias is influenced by female sex.
Conclusion
In mitral valve prolapse without significant mitral regurgitation, interstitial fibrosis is associated with an increased risk of arrhythmic events, particularly in females.
Supporting Evidence
- 38% of MVP cases were classified as AMVP.
- Global ECV% was significantly higher in AMVP vs non-AMVP.
- ECV% remained independently associated with an increased risk of arrhythmic events.
- The association between AMVP and global ECV% was driven by female sex.
Takeaway
This study found that women with a heart condition called mitral valve prolapse have more heart muscle scarring, which can lead to dangerous heart rhythms.
Methodology
The study involved contrast CMR in consecutive individuals with mitral valve prolapse from 2019 to 2022, measuring extracellular volume fraction (ECV%) and assessing arrhythmic events.
Limitations
The study's sample size may limit the statistical power to detect certain associations, and the sex-specific thresholds for abnormal ECV% were derived from a small sample size.
Participant Demographics
30 women (46%) and 35 men (54%) with a mean age of 55 years.
Statistical Information
P-Value
p=0.002
Confidence Interval
31% [27-33] vs 27% [23-30]
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website